Vericel Corp (VCEL)
56.72
-0.54
(-0.94%)
USD |
NASDAQ |
Nov 21, 16:00
56.72
0.00 (0.00%)
After-Hours: 20:00
Vericel Market Cap: 2.800B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 2.826B |
| November 19, 2024 | 2.756B |
| November 18, 2024 | 2.611B |
| November 15, 2024 | 2.590B |
| November 14, 2024 | 2.603B |
| November 13, 2024 | 2.738B |
| November 12, 2024 | 2.759B |
| November 11, 2024 | 2.803B |
| November 08, 2024 | 2.665B |
| November 07, 2024 | 2.469B |
| November 06, 2024 | 2.371B |
| November 05, 2024 | 2.209B |
| November 04, 2024 | 2.190B |
| November 01, 2024 | 2.171B |
| October 31, 2024 | 2.174B |
| October 30, 2024 | 2.244B |
| October 29, 2024 | 2.258B |
| October 28, 2024 | 2.249B |
| October 25, 2024 | 2.155B |
| October 24, 2024 | 2.112B |
| October 23, 2024 | 2.083B |
| October 22, 2024 | 2.061B |
| October 21, 2024 | 2.029B |
| October 18, 2024 | 2.052B |
| October 17, 2024 | 2.004B |
| Date | Value |
|---|---|
| October 16, 2024 | 2.033B |
| October 15, 2024 | 2.067B |
| October 14, 2024 | 2.074B |
| October 11, 2024 | 2.054B |
| October 10, 2024 | 1.975B |
| October 09, 2024 | 2.017B |
| October 08, 2024 | 2.037B |
| October 07, 2024 | 2.023B |
| October 04, 2024 | 2.136B |
| October 03, 2024 | 2.037B |
| October 02, 2024 | 2.005B |
| October 01, 2024 | 1.973B |
| September 30, 2024 | 2.081B |
| September 27, 2024 | 2.118B |
| September 26, 2024 | 2.161B |
| September 25, 2024 | 2.167B |
| September 24, 2024 | 2.194B |
| September 23, 2024 | 2.274B |
| September 20, 2024 | 2.283B |
| September 19, 2024 | 2.355B |
| September 18, 2024 | 2.273B |
| September 17, 2024 | 2.173B |
| September 16, 2024 | 2.193B |
| September 13, 2024 | 2.249B |
| September 12, 2024 | 2.171B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
325.86M
Minimum
Mar 18 2020
3.143B
Maximum
Jun 28 2021
1.622B
Average
1.619B
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals Inc | 2.520B |
| Exelixis Inc | 9.945B |
| Halozyme Therapeutics Inc | 5.818B |
| ADMA Biologics Inc | 5.034B |
| Natera Inc | 22.37B |
Market Cap Related Metrics
| PE Ratio | 810.29 |
| PS Ratio | 12.11 |
| Price to Book Value | 10.87 |
| Price | 56.72 |
| Earnings Yield | 0.12% |
| Normalized PE Ratio | 810.29 |